Literature DB >> 33857399

Countries with high deaths due to flu and tuberculosis demonstrate lower COVID-19 mortality: roles of vaccinations.

Sanmoy Pathak1, Mohit Kumar Jolly2, Dipankar Nandi1.   

Abstract

Deaths due to the ongoing COVID-19 pandemic vary (3-1681 deaths/million and mortality rates 0.71-14.54%) and are far greater in some countries compared to others. This observation led us to perform epidemiological analysis, using data in the public domain, to study the correlation of COVID-19 with the prevalence and vaccination strategies for two respiratory pathogens: flu and tuberculosis (TB). Countries showing more than 1000 COVID-19 deaths were selected at three time points during the ongoing pandemic: 17 May, 1 October and 31 December 2020. The major findings of this study that are broadly consistent at all three time points are: First, countries with high flu deaths negatively correlate with COVID-19 deaths/million. Second, TB incidences and deaths negatively correlate with COVID-19 deaths/million. Countries displaying high TB and flu deaths (Nigeria, Ethiopia, Myanmar, Indonesia, India) display lower COVID-19 deaths/million compared to countries with low TB and flu deaths (Italy, Spain, USA, France). Third, countries with greater flu vaccination display lower flu incidences but higher COVID-19 deaths/million and mortality rates. On the other hand, Bacillus Calmette Guerin (BCG) vaccination negatively correlates with Covid-19 deaths/million. Fourth, countries with only BCG, but no flu, vaccination show delayed and lower number of COVID-19 deaths/million compared to countries with flu, but no BCG, vaccination. Fifth, countries with high BCG vaccination coverage as well as high TB deaths display the lowest COVID-19 deaths/million. The implications of this global study are discussed with respect to the roles of respiratory infections and vaccinations in lowering COVID-19 deaths.

Entities:  

Keywords:  BCG; COVID-19; flu; tuberculosis; vaccinations

Mesh:

Substances:

Year:  2021        PMID: 33857399      PMCID: PMC8381816          DOI: 10.1080/21645515.2021.1908058

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  48 in total

1.  Nonspecific (Heterologous) Protection of Neonatal BCG Vaccination Against Hospitalization Due to Respiratory Infection and Sepsis.

Authors:  María José de Castro; Jacobo Pardo-Seco; Federico Martinón-Torres
Journal:  Clin Infect Dis       Date:  2015-02-27       Impact factor: 9.079

2.  Seasonal influenza immunisation in Europe. Overview of recommendations and vaccination coverage for three seasons: pre-pandemic (2008/09), pandemic (2009/10) and post-pandemic (2010/11).

Authors:  J Mereckiene; S Cotter; A Nicoll; P Lopalco; T Noori; Jt Weber; F D'Ancona; D Levy-Bruhl; L Dematte; C Giambi; P Valentiner-Branth; I Stankiewicz; E Appelgren; D O Flanagan
Journal:  Euro Surveill       Date:  2014-04-24

Review 3.  Virological and Immunological Outcomes of Coinfections.

Authors:  Naveen Kumar; Shalini Sharma; Sanjay Barua; Bhupendra N Tripathi; Barry T Rouse
Journal:  Clin Microbiol Rev       Date:  2018-07-05       Impact factor: 26.132

4.  Complement and tissue factor-enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis.

Authors:  Panagiotis Skendros; Alexandros Mitsios; Akrivi Chrysanthopoulou; Dimitrios C Mastellos; Simeon Metallidis; Petros Rafailidis; Maria Ntinopoulou; Eleni Sertaridou; Victoria Tsironidou; Christina Tsigalou; Maria Tektonidou; Theocharis Konstantinidis; Charalampos Papagoras; Ioannis Mitroulis; Georgios Germanidis; John D Lambris; Konstantinos Ritis
Journal:  J Clin Invest       Date:  2020-11-02       Impact factor: 14.808

5.  Long-term efficacy of BCG vaccine in American Indians and Alaska Natives: A 60-year follow-up study.

Authors:  Naomi E Aronson; Mathuram Santosham; George W Comstock; Robin S Howard; Lawrence H Moulton; Everett R Rhoades; Lee H Harrison
Journal:  JAMA       Date:  2004-05-05       Impact factor: 56.272

6.  Tuberculosis in Asia and the pacific: the role of socioeconomic status and health system development.

Authors:  Jie Wu; Koustuv Dalal
Journal:  Int J Prev Med       Date:  2012-01

7.  BCG-Induced Trained Immunity in Healthy Individuals: The Effect of Plasma Muramyl Dipeptide Concentrations.

Authors:  Vera P Mourits; Valerie A C M Koeken; L Charlotte J de Bree; Simone J C F M Moorlag; Wern Cui Chu; Xiaoli Xu; Helga Dijkstra; Heidi Lemmers; Leo A B Joosten; Yue Wang; Reinout van Crevel; Mihai G Netea
Journal:  J Immunol Res       Date:  2020-06-15       Impact factor: 4.818

8.  A pneumonia outbreak associated with a new coronavirus of probable bat origin.

Authors:  Peng Zhou; Xing-Lou Yang; Xian-Guang Wang; Ben Hu; Lei Zhang; Wei Zhang; Hao-Rui Si; Yan Zhu; Bei Li; Chao-Lin Huang; Hui-Dong Chen; Jing Chen; Yun Luo; Hua Guo; Ren-Di Jiang; Mei-Qin Liu; Ying Chen; Xu-Rui Shen; Xi Wang; Xiao-Shuang Zheng; Kai Zhao; Quan-Jiao Chen; Fei Deng; Lin-Lin Liu; Bing Yan; Fa-Xian Zhan; Yan-Yi Wang; Geng-Fu Xiao; Zheng-Li Shi
Journal:  Nature       Date:  2020-02-03       Impact factor: 69.504

9.  ACE/ACE2 ratio and MMP-9 activity as potential biomarkers in tuberculous pleural effusions.

Authors:  Wen-Yeh Hsieh; Tang-Ching Kuan; Kun-Shan Cheng; Yan-Chiou Liao; Mu-Yuan Chen; Pei-Heng Lin; Yuan-Chang Hsu; Chen-Yi Huang; Wei-Hua Hsu; Sheng-Yao Yu; Chih-Sheng Lin
Journal:  Int J Biol Sci       Date:  2012-10-17       Impact factor: 6.580

10.  Long-lasting effects of BCG vaccination on both heterologous Th1/Th17 responses and innate trained immunity.

Authors:  Johanneke Kleinnijenhuis; Jessica Quintin; Frank Preijers; Christine Stabell Benn; Leo A B Joosten; Cor Jacobs; Joke van Loenhout; Ramnik J Xavier; Peter Aaby; Jos W M van der Meer; Reinout van Crevel; Mihai G Netea
Journal:  J Innate Immun       Date:  2013-10-30       Impact factor: 7.349

View more
  3 in total

Review 1.  BCG Vaccination: A potential tool against COVID-19 and COVID-19-like Black Swan incidents.

Authors:  Wenping Gong; Yingqing Mao; Yuexi Li; Yong Qi
Journal:  Int Immunopharmacol       Date:  2022-05-17       Impact factor: 5.714

2.  The Natural Effect of BCG Vaccination on COVID-19: The Debate Continues.

Authors:  Wenping Gong; Huiru An; Jie Wang; Peng Cheng; Yong Qi
Journal:  Front Immunol       Date:  2022-07-08       Impact factor: 8.786

Review 3.  COVID-19 Pandemic Disruption on the Management of Tuberculosis Treatment in Indonesia.

Authors:  Gabriella J Caren; Deni Iskandar; Dian A E Pitaloka; Rizky Abdulah; Auliya A Suwantika
Journal:  J Multidiscip Healthc       Date:  2022-01-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.